GlassScriptPhysician profile
Sheila Mariano
NPI 1104896919
$1,874.67
in general payments reported to CMS, 2019-2025
19 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $116 · 2021: $83.90 · 2022: $373 · 2023: $330 · 2024: $285 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $249.65 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $239.57 | 2019-2025 | Mounjaro, Zepbound |
| Amgen INC. | $213.95 | 2019-2024 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $177.28 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $171.63 | 2019-2025 | Gardasil 9, Capvaxive |
| Abbvie INC. | $110.33 | 2019-2025 | |
| Abbott Laboratories | $107.57 | 2021-2024 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.89 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $86.73 | 2022 | |
| Alpha Cognition USA, INC. | $86.56 | 2025 | Zunveyl |
| Novartis Pharmaceuticals Corporation | $77.74 | 2019-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $77.49 | 2023 | Imbruvica |
| Janssen Pharmaceuticals, INC | $66.82 | 2019 | |
| Avanir Pharmaceuticals, INC. | $29.20 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.91 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $19.18 | 2025 | Omnipod |
| Sanofi-Aventis U.S. LLC | $15.78 | 2019 | |
| Pfizer INC. | $14.42 | 2025 | |
| Esperion Therapeutics, INC. | $13.97 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Mariano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.